Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
(Cancer Drug Discovery and Development)
(Cancer Drug Discovery and Development) (Hardcover)
by William D. Figg (Editor), Howard L. McLeod
Editorial Reviews
(Cancer Drug Discovery and Development)
(Cancer Drug Discovery and Development) (Hardcover)
by William D. Figg (Editor), Howard L. McLeod
Editorial Reviews
Review
"...an invaluable overview of the experimental and clinical processes that lead to anticancer drugs, creating a single indispensable reference that covers all the steps from the identification of cancer-specific targets to phase III clinical trials." - Tumori
Product Description
Leading investigators synthesize the entire laboratory and clinical process of developing anticancer drugs to create a single indispensable reference that covers all the steps from the identification of cancer-specific targets to phase III clinical trials. These expert authors provide their best guidance on a wide variety of issues, including clinical trial design, preclinical screening, and the development and validation of bioanalytic methods. The chapters on identifying agents to test in phase III trials and on trial design for the approval of new anticancer agents offer a unique roadmap for moving an agent to NDA submission.
"...an invaluable overview of the experimental and clinical processes that lead to anticancer drugs, creating a single indispensable reference that covers all the steps from the identification of cancer-specific targets to phase III clinical trials." - Tumori
Product Description
Leading investigators synthesize the entire laboratory and clinical process of developing anticancer drugs to create a single indispensable reference that covers all the steps from the identification of cancer-specific targets to phase III clinical trials. These expert authors provide their best guidance on a wide variety of issues, including clinical trial design, preclinical screening, and the development and validation of bioanalytic methods. The chapters on identifying agents to test in phase III trials and on trial design for the approval of new anticancer agents offer a unique roadmap for moving an agent to NDA submission.
Product Details
Hardcover: 640 pages
Publisher: Humana Press; 1 edition
(March 26, 2004)
Language: English
ISBN-10: 1588291774
ISBN-13: 978-1588291776
Product Dimensions: 10 x 6.8 x 1.4 inches
Shipping Weight: 2.8 pounds
Download from here
http://rapidshare.com/files/34082893/Fig_HaboooAncaPhkiaPhdy.rar
(5567 KB)
Publisher: Humana Press; 1 edition
(March 26, 2004)
Language: English
ISBN-10: 1588291774
ISBN-13: 978-1588291776
Product Dimensions: 10 x 6.8 x 1.4 inches
Shipping Weight: 2.8 pounds
Download from here
http://rapidshare.com/files/34082893/Fig_HaboooAncaPhkiaPhdy.rar
(5567 KB)